z-logo
open-access-imgOpen Access
Inhibition of NLRC5 attenuates the malignant growth and enhances the sensitivity of gastric cancer cells to 5‑FU chemotherapy by blocking the carcinogenic effect of YY1
Author(s) -
Liang Shan,
T. Xiang,
Shiyu Liu,
Wei Xiang
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11538
Subject(s) - oncogene , cancer , blocking (statistics) , cancer research , oncology , chemotherapy , molecular medicine , apoptosis , cell cycle , carcinogen , medicine , biology , computer science , genetics , computer network

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom